Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Dynogen raises $13.25mm in first round

Executive Summary

Dynogen Pharmaceuticals (therapies for genitourinary and gastrointestinal disorders) raised $13.25mm in its first round of financing, which was led by Oxford Bioscience Partners (OBP) and Healthcare Ventures, and included AM Pappas & Associates (AMP&A).
Deal Industry
  • Biotechnology
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Financing
    • Private Placement

Related Companies